Understanding Genetic Testing and Health Screening in Poodles
Health testing in breeding dogs is one of those topics where the gap between what buyers are told and what they actually need to know is wide enough to matter. The phrase “health tested” appears in the marketing of nearly every breeder with a website, but it covers an enormous range of practices, from the single DNA swab that took five minutes to the comprehensive orthopedic, ophthalmologic, and genetic panel that cost several hundred dollars and required veterinary specialists. Treating those two things as equivalent, because both get filed under the same three-word phrase, is a meaningful mistake for anyone buying a Poodle or a Poodle cross.
This guide explains what the testing categories actually mean, why each one exists, and what responsible Poodle breeders are doing in each area based on the guidance of the Poodle Club of America, the Orthopedic Foundation for Animals, and the accumulated veterinary research on this breed’s specific health vulnerabilities. The goal is not to turn a puppy buyer into a genetics technician. It is to give families enough understanding of the testing landscape to ask the right questions, read a breeder’s health documentation accurately, and verify claims independently through the OFA’s publicly searchable database.
We are writing this specifically for Poodles and for the Bernedoodle cross, where the Poodle parent’s health profile is directly relevant to the offspring’s long-term health outcomes. A Bernedoodle inherits health risks from both parent breeds, and understanding which risks come from the Poodle side, which come from the Bernese Mountain Dog side, and which of each have reliable screening tools available is the foundation of what responsible Bernedoodle breeding looks like in practice.
The Orthopedic Foundation for Animals, founded in 1966, is the largest and most comprehensive canine health registry in the United States. It maintains publicly searchable databases of health testing results across dozens of conditions and breeds, and its records are the primary tool available to puppy buyers for independently verifying health claims. When a breeder says a parent dog has an OFA number for hips, elbows, or any other condition, that number is searchable at ofa.org by the dog’s registered name, AKC registration number, or microchip number, and the results are publicly visible. This searchability is not incidental. It is the accountability mechanism that separates a health claim supported by an external record from a health claim that exists only in a conversation with the breeder.
The Canine Health Information Center program, administered through the OFA in partnership with each breed’s parent club, establishes minimum testing requirements for breeding dogs and issues CHIC numbers to dogs that complete them. For Poodles, the Poodle Club of America determines what those requirements are. A CHIC number signals that a dog has completed the minimum required testing for its variety and that the results are in the public database. Two nuances here are important enough to state plainly. First, a CHIC number does not mean the dog passed every test, only that the required tests were completed and submitted. The OFA’s own description of the CHIC program states this directly: for CHIC certification, all results do not need to be normal, but they must all be in the public domain. Second, CHIC represents a minimum. The United Poodle Association’s health guidance notes that the minimum testing if you want to get a CHIC number does not mean these tests are sufficient to help reduce risk of common diseases in the breed, and that educated responsible breeders test well beyond CHIC standards. CHIC is a floor, not a ceiling.
Orthopedic conditions represent the most directly visible health consequence of irresponsible breeding in large and medium-sized dogs: a dog with hip dysplasia may live years with pain that goes unrecognized because it has adapted to it gradually, and the arthritis that develops from dysplastic joints is both expensive to manage and genuinely diminishes quality of life. For Standard Poodles, whose size places them in the hip dysplasia risk category for large breeds, and for Bernedoodle crosses where Bernese Mountain Dog hip and elbow disease rates have historically been a significant concern, orthopedic evaluation of breeding dogs is among the most consequential health investments a program makes.
Hip Dysplasia Evaluation: OFA vs. PennHIP
The OFA method for hip evaluation involves radiographs taken with the dog in a specific extended position, reviewed by a panel of three board-certified veterinary radiologists who issue a consensus grade. The grades are: Excellent, Good, and Fair (all considered normal and certifiable), Borderline (not certifiable), and Mild, Moderate, and Severe dysplasia (all failing). For an OFA certification to be valid for the dog’s lifetime, the evaluation must be done after the dog reaches 24 months of age. Preliminary evaluations, available earlier, are informational but not certifications and do not appear in the OFA database as clearances. The OFA’s hip grades reflect the subjective assessment of joint conformation at the time of the radiograph by three specialists, with the consensus of at least two of the three determining the final grade.
PennHIP, developed at the University of Pennsylvania School of Veterinary Medicine, takes a different measurement approach. Rather than grading joint conformation subjectively, PennHIP quantitatively measures hip joint laxity, the degree of looseness in the hip socket, using a distraction index derived from three specific radiographic projections taken while the dog is under general anesthesia. The distraction index compares the dog to a breed-specific population, expressing the result as a percentile within that breed’s database. PennHIP can be done as early as four months of age and its results are valid for the lifetime of the dog. Research supports PennHIP as able to detect hip dysplasia risk earlier than OFA’s extended-position radiograph, and it is increasingly preferred by rigorous breeding programs as an adjunct to or replacement for traditional OFA hip evaluation. Both methods are accepted by the Poodle Club of America for CHIC certification. High Desert Companions’ Poodle health testing documentation describes PennHIP as measuring hip joint laxity to assess early risk of developing hip dysplasia, noting it is more precise than standard OFA scoring.
Elbow Dysplasia
Elbow dysplasia is a collective term for several developmental orthopedic conditions affecting the elbow joint, including fragmented coronoid process, osteochondrosis, and ununited anconeal process. OFA evaluates elbow radiographs and issues a grade of normal or grades I through III of dysplasia. Elbow certification requires the dog to be at least 24 months old. Elbow evaluation is required for Standard Poodles in the PCA’s CHIC protocol and is strongly recommended for Miniature Poodles, particularly when used in crosses with breeds known for elbow disease such as the Bernese Mountain Dog.
Patellar Luxation
Patellar luxation, the slipping of the kneecap from its normal groove in the femur, is among the most common orthopedic conditions in small breeds and is specifically relevant to Toy and Miniature Poodles. The OFA grades patella evaluations on a scale from normal to Grade IV luxation, with Grades I and II representing mild to moderate slipping that does not always require surgical intervention and Grades III and IV representing severe luxation that typically does. The Poodle Club of America requires patellar evaluation as part of the CHIC protocol for all Poodle varieties, with evaluation possible after 12 months of age. For Miniature Poodles specifically, patellar health is one of the conditions the PCA foundation most urgently flags as a breeding priority, noting that a significant portion of Miniature Poodles carry orthopedic vulnerabilities in this area.
Legg-Calvé-Perthes Disease
Legg-Calvé-Perthes disease is a disorder of hip joint conformation specific to small breeds, in which the blood supply to the femoral head is disrupted, leading to degeneration of the hip joint. Versatility in Poodles’ testing guidance notes that it is most often seen in Miniature and Toy breeds between four months and one year of age, and that OFA evaluates radiographs and certifies whether a dog is clear. Dogs that receive a normal OFA hip evaluation are simultaneously considered normal for LCP, with the LCP number issued without additional charge. While technically listed as recommended rather than required by the PCA for Toy Poodles, it deserves attention particularly in small-variety breeding programs.
| Orthopedic Test | Toy Poodle | Miniature Poodle | Standard Poodle | Minimum Age |
|---|---|---|---|---|
| Hip Dysplasia (OFA or PennHIP) | Not required (low risk) | Required for CHIC | Required for CHIC | 24 months (OFA); 4 months (PennHIP) |
| Elbow Dysplasia | Not required | Strongly recommended | Required for CHIC | 24 months |
| Patellar Luxation | Required for CHIC | Required for CHIC | Required for CHIC | 12 months |
| Legg-Calvé-Perthes | Recommended | Recommended | Not required | Concurrent with hip OFA |
Eye health screening in Poodles operates on two parallel tracks that address two different things, and both are required by the Poodle Club of America. Understanding why both are necessary, rather than treating one as redundant to the other, matters for evaluating a breeder’s program honestly.
The CAER Examination
The Companion Animal Eye Registry examination, commonly called the CAER exam, is a physical examination of the eye conducted by a board-certified veterinary ophthalmologist, a specialist with an ACVO (American College of Veterinary Ophthalmologists) diplomate designation. The examination screens for a range of heritable eye conditions including cataracts, progressive retinal atrophy, retinal dysplasia, persistent pupillary membranes, distichiasis, optic nerve hypoplasia, and micropapilla. The results are registered with the OFA and the certification is valid for twelve months from the date of the exam.
The twelve-month validity period is not administrative bureaucracy. It reflects the nature of what is being screened: many hereditary eye conditions are progressive and may not be visible on examination early in the dog’s life. The Versatility in Poodles health guidance is specific about this: it is possible for a clinically normal animal to have a genetic abnormality that may result in a clinically detectable eye disorder later in life, which is why it is important to repeat CAER exams on a regular schedule, with yearly recommended for breeding animals even after they are no longer being bred. A CAER exam from three years ago tells you what the ophthalmologist found three years ago. It does not tell you what that dog’s eyes look like today, which is why responsible breeding programs maintain current certifications throughout a dog’s breeding life rather than treating a single exam as permanent clearance.
prcd-PRA DNA Testing
Progressive rod-cone degeneration progressive retinal atrophy, called prcd-PRA, is the most common heritable cause of blindness in Poodles across all three size varieties. It is inherited as an autosomal recessive trait, meaning a dog must inherit two copies of the affected variant, one from each parent, to develop the disease. Dogs with one copy are carriers: they do not develop the disease themselves but can pass the variant to offspring. The condition causes gradual degeneration of the photoreceptor cells in the retina, beginning with night blindness and progressing to complete blindness, typically becoming apparent between three and eight years of age depending on the individual dog. There is no treatment.
The DNA test for prcd-PRA produces one of three results: Clear (the dog carries no copies of the causative variant and cannot produce affected offspring regardless of the mate’s status), Carrier (the dog carries one copy and can produce affected offspring if bred to another carrier), or Affected (the dog carries two copies and will develop the disease). A dog that tests Clear on the prcd-PRA DNA test cannot become Carrier or Affected: the result is permanent and does not require updating. This is the key distinction between DNA testing and CAER examination. The DNA test tells you what is in the genetic code, which does not change. The CAER exam tells you what the eye looks like now, which can change.
An important nuance: prcd-PRA is the most common form of PRA in Poodles, but it is not the only form. DNA testing Clear for prcd-PRA means the dog does not carry that specific variant; it does not certify the dog against all forms of heritable retinal disease. This is why the CAER examination remains necessary alongside a clear prcd-PRA DNA result: the exam can detect eye abnormalities that the DNA test does not screen for. The Versatility in Poodles documentation is explicit: Poodles may have eye abnormalities including progressive retinal atrophy, optic nerve hypoplasia, distichiasis, micropapilla, and microphthalmia, and PRA is considered hereditary while some other eye abnormalities are presumed hereditary. A clear DNA test for one form of PRA does not substitute for the annual exam.
DNA-based genetic testing for specific heritable conditions has expanded dramatically in the last fifteen years, and the list of conditions with validated tests grows as canine genetics research progresses. The conditions described below represent those with the strongest evidence base and the clearest testing guidance for Poodle breeding programs, organized from the most broadly applicable to the more variety-specific. Not every condition has an equally well-validated test, and breeders should understand the difference between tests developed from large study populations with robust clinical validation and tests based on early or limited research.
Progressive Rod-Cone Degeneration PRA (prcd-PRA)
Covered in detail in the eye section above. The most common heritable cause of blindness in the breed. Produces gradual retinal degeneration progressing from night blindness to complete vision loss, typically between three and eight years of age. No treatment exists. DNA testing identifies Clear, Carrier, and Affected status permanently. Responsible breeding programs do not breed two carriers together, which eliminates the statistical risk of producing affected offspring.
Neonatal Encephalopathy with Seizures (NEwS)
NEwS is a fatal neurological disease specific to Standard Poodles. Affected puppies are born weak and uncoordinated, with seizures beginning shortly after birth. A 2020 peer-reviewed study published in Frontiers in Veterinary Science identified the causal genetic variant as a homozygous missense mutation in the ATF2 gene (c.152T>G), and MRI findings in affected puppies showed reduced brain size, dilated ventricles, and white matter abnormalities. According to Embark’s breed health data, approximately 1.1 percent of Standard Poodles in their database carry the variant, making carrier-to-carrier breedings a meaningful risk at population scale. The Poodle Club of America recommends NEwS DNA testing for Standard Poodle breeders. The disease is entirely preventable through testing: two Clear parents cannot produce an affected puppy.
Von Willebrand Disease Type I (vWD)
Von Willebrand Disease is a bleeding disorder caused by a deficiency or dysfunction of von Willebrand factor, a protein essential to normal blood clotting. Type I, the form found in Standard Poodles, typically causes mild to moderate bleeding abnormalities: prolonged bleeding from minor wounds, nosebleeds, or excessive surgical bleeding. According to Embark’s breed data, approximately 1.6 percent of tested Standard Poodles carry the variant, with less than 0.1 percent testing at-risk. A DNA test identifies carrier and affected status. Dogs with vWD Type I can often live normal lives with appropriate veterinary management, but the condition is relevant to disclose to puppy buyers because it affects anesthetic protocols and surgical planning throughout the dog’s life.
GM2 Gangliosidosis (HEXB variant, Poodle type)
GM2 gangliosidosis is a lysosomal storage disease caused by a deficiency of the enzyme beta-hexosaminidase, resulting in the toxic accumulation of gangliosides in the nervous system. UC Davis Veterinary Genetics Laboratory, which validated the Poodle-specific test, describes the disease as fatal and neurodegenerative: affected dogs display tremor, incoordination, difficulty eating, and progressive neurological deterioration beginning at nine to twelve months of age, with death typically occurring within six to twelve months of onset. The disease has a human equivalent called Sandhoff disease. DNA testing identifies carriers and affected dogs; two carriers bred together produce, on average, twenty-five percent affected offspring. The test is available through the UC Davis VGL and several commercial laboratories.
Osteochondrodysplasia / Miniature Poodle Dwarfism (SLC13A1)
Osteochondrodysplasia in Miniature Poodles is a skeletal dwarfism disorder caused by a variant in the SLC13A1 gene. The Poodle Club of America Foundation’s guidance is direct: research suggests that approximately ten percent of Miniature Poodles carry the mutation that causes this disease, and that it is not limited to a few bloodlines. Affected dogs develop a deforming and crippling skeletal dysplasia. The carrier frequency of roughly one in ten Miniature Poodles means that carrier-to-carrier breedings are statistically likely without deliberate testing and avoidance. This is one of the most urgently under-tested conditions in the Miniature Poodle population relative to its carrier rate.
Degenerative Myelopathy (DM, SOD1A variant)
Degenerative myelopathy is a progressive neurological disease of the spinal cord that causes gradual hindlimb weakness progressing to paralysis, analogous to ALS in humans. The SOD1A variant tested in dogs is associated with DM in multiple breeds. The penetrance of this variant, meaning the proportion of at-risk dogs that actually develop the disease, is known to be breed-specific and incomplete: not all dogs with two copies of the variant develop DM. Embark’s guidance on interpreting DM results is appropriately calibrated: dogs with two copies of the variant should be considered at elevated risk but the variant’s penetrance makes individual outcome prediction uncertain. For breeding purposes, avoiding at-risk-by-at-risk pairings remains the standard recommendation regardless of the penetrance uncertainty.
Three conditions sit at the top of Standard Poodle health concern lists and share an important characteristic: as of this writing, none has a reliable, validated DNA test available for breeding use. They are heritable in the sense that they run in families and have a genetic component, but the genetics are polygenic and complex rather than the simple Mendelian inheritance patterns that produce clean Clear/Carrier/Affected results. This does not mean responsible breeders ignore them. It means the tools available for managing them are pedigree analysis, transparency about family history, and watchful owner education rather than a DNA test result.
Addison’s Disease (Hypoadrenocorticism)
Addison’s disease occurs when the adrenal glands fail to produce sufficient cortisol and aldosterone, the hormones that regulate stress response and electrolyte balance. In dogs, as documented in a 2015 research study published in BMC Genomics examining 761 Standard, Miniature, and Miniature/Standard Poodle crosses, Addison’s disease increased rapidly in incidence among Standard Poodles after the mid-twentieth century, driven by a period of close linebreeding around popular bloodlines. The study identified this as the “mid-century bottleneck,” in which genetic diversity was reduced and disease-associated haplotypes became fixed across the population. The United Poodle Association’s health guidance is direct: Addison’s disease is a frequent health issue in Standard Poodles and there is currently no predictive DNA test. Signs include lethargy, vomiting, weight loss, and weakness; acute Addisonian crises can be life-threatening and require emergency veterinary care. Dogs with a confirmed diagnosis can be managed with hormone replacement therapy and live normal lives, but the condition requires monitoring and ongoing medication.
Sebaceous Adenitis
Sebaceous adenitis is an autoimmune skin disease in which the immune system attacks and destroys the sebaceous (oil) glands, resulting in dry, scaly skin, progressive hair loss, and chronic secondary infections, particularly in Standard Poodles. The same 2015 genetics study linked SA’s increased prevalence to the same mid-century linebreeding pattern as Addison’s disease. OFA maintains a sebaceous adenitis registry that accepts skin punch biopsy results evaluated by an OFA-approved dermatopathologist, and SA biopsy is included as one of the health elective options in the Standard Poodle’s CHIC protocol. The United Poodle Association’s guidance notes that testing for SA is controversial because the disease may only appear in one part of a dog’s body, making a single biopsy potentially inconclusive, and that a dog testing negative at one point in time could test positive later. Reputable Standard Poodle breeders include SA biopsy in their programs and discuss family histories honestly, recognizing it as a management challenge rather than a solvable problem through current technology alone.
Gastric Dilatation-Volvulus (GDV/Bloat)
GDV is a life-threatening emergency condition in which the stomach fills with gas and then rotates on its axis, trapping the gas and cutting off blood circulation to the stomach and other abdominal organs. Standard Poodles, as a deep-chested large breed, are in the at-risk category for GDV along with breeds like Great Danes, German Shepherds, and Weimaraners. The United Poodle Association’s health resources note that GDV is a frequent health issue in Standard Poodles and that there is a genetic component alongside environmental factors: tall, narrow-bodied dogs are at higher baseline risk, and dogs that eat or drink rapidly or in large quantities are more susceptible. There is currently no DNA test for GDV risk. The primary management tools are owner education about signs, preventive gastropexy (a surgical procedure that tacks the stomach to the body wall to prevent rotation, often performed at the time of spay or neuter in at-risk breeds), and feeding management practices that reduce the risk of rapid consumption.
The gap between a breeder who health tests and one who describes themselves as health testing without equivalent substance is not visible in marketing language. It is visible in the specifics of what they have done, when they did it, and whether it can be independently verified. The checklist below represents the minimum verification a buyer should complete before purchasing a Poodle or Bernedoodle from any breeder, regardless of how impressive their website or how warm their communication.
- Ask for the registered names of both parent dogs and use them to search the OFA database directly at ofa.org. Do not rely on the breeder’s summary of the results. The OFA database is public specifically to enable this verification, and any breeder whose dogs do not appear there or whose listed results do not match what the breeder has claimed should be asked to explain the discrepancy before proceeding.
- Distinguish between OFA certifications and OFA preliminary evaluations. A preliminary hip or elbow evaluation done at twelve months is informational but not a lifetime certification. The OFA’s certification age for hips is 24 months. A breeding program that uses preliminary evaluations as the basis for breeding decisions is taking a shortcut that matters for the offspring’s health outcomes.
- Verify that CAER eye certifications are current. Eye certifications are valid for twelve months. A CAER certification from two or three years ago is expired. Ask when the most recent eye exam was done and confirm the date in the OFA database, where current CAER results are posted by participating ophthalmologists.
- Ask specifically about prcd-PRA DNA testing, not only about eye exams. A current CAER exam and a clear prcd-PRA DNA test are two different things that address two different questions. A breeder who has only one of the two should be asked why, and the answer should be satisfying before you proceed.
- Ask which additional DNA tests have been done beyond the CHIC minimum. For Standard Poodles, the PCA specifically recommends NEwS and vWD testing beyond the CHIC requirements. For Miniature Poodles, osteochondrodysplasia testing is strongly recommended given its carrier frequency. A breeder who is doing only the minimum should be able to explain their reasoning for not going further.
- Ask about the family histories of Addison’s disease, sebaceous adenitis, and bloat in Standard Poodle or Standard Bernedoodle programs. These conditions have no DNA tests, but honest breeders know their lines and discuss this information transparently rather than deflecting. A breeder who claims their lines have no history of these conditions at all, without qualification, may not be tracking outcomes carefully enough to know.
At a Glance: Poodle Health Testing by Variety
| Test | Toy Poodle | Miniature Poodle | Standard Poodle | Frequency |
|---|---|---|---|---|
| Hip Dysplasia (OFA or PennHIP) | Not required | CHIC required | CHIC required | Once (OFA 24+ mo; PennHIP 4+ mo) |
| Elbow Dysplasia | Not required | Recommended | CHIC required | Once (24+ months) |
| Patellar Luxation | CHIC required | CHIC required | CHIC required | Once (12+ months) |
| CAER Eye Exam (Ophthalmologist) | CHIC required | CHIC required | CHIC required | Annual |
| prcd-PRA DNA Test | CHIC required | CHIC required | CHIC required | Once (permanent) |
| NEwS DNA Test | Not applicable | Not applicable | PCA recommended | Once (permanent) |
| vWD Type I DNA Test | Not applicable | Not required | PCA recommended | Once (permanent) |
| Osteochondrodysplasia DNA Test | Not applicable | Strongly recommended | Not required | Once (permanent) |
| GM2 Gangliosidosis DNA Test | Recommended | Recommended | Recommended | Once (permanent) |
| Sebaceous Adenitis Biopsy | Not required | Not required | CHIC elective option | Ongoing; can develop later |
| Thyroid (OFA) | Not required | Not required | CHIC elective option | Annual or per protocol |
Frequently Asked Questions
A breeder told me their dogs are “health tested” but the parents aren’t in the OFA database. Is that a problem?
It depends on what specifically was tested and why it is not in the database, but the absence of OFA records is worth investigating directly rather than accepting at face value. There are legitimate reasons results may not appear publicly: some DNA tests are submitted to laboratories that do not automatically upload to OFA, and some international or at-home tests produce valid results that are not registered. But the OFA database is the established accountability mechanism for canine health testing in the United States precisely because public records prevent misrepresentation. A breeder who has done the testing should be able to provide copies of original certificates from the evaluating veterinarian, ophthalmologist, or laboratory for every test they claim. If the certificates are unavailable, or if the breeder is unwilling to provide them or submit results to OFA, that is a meaningful signal about the program’s transparency standards. A breeder who is genuinely committed to health testing and has nothing to hide submits results publicly, because the whole point of the infrastructure is shared accountability rather than a conversation between a buyer and the person who has a financial interest in the outcome.
What is the difference between a dog that is a carrier for a recessive condition and one that is affected? Should I worry if a parent dog is a carrier?
For conditions inherited in an autosomal recessive pattern, a carrier dog carries one copy of the disease-associated variant and one normal copy. Carriers do not develop the disease themselves. They can only produce affected offspring if bred to another carrier, which gives each offspring a one-in-four statistical chance of inheriting two copies and being affected. A carrier parent bred to a clear parent produces, on average, fifty percent carrier and fifty percent clear offspring, with zero percent affected. This means that carrier parent dogs are not disqualified from responsible breeding programs; they simply must be paired with dogs that have been tested and confirmed clear. Embark’s guidance on breeding decisions states this explicitly: depending on the health condition and how many copies your dog has inherited, you may not have to remove them from your breeding program. The appropriate response to a carrier result is not to remove the dog from the gene pool, which would narrow genetic diversity unnecessarily, but to test every potential breeding partner and never pair two carriers. A responsible breeder who discloses a parent dog’s carrier status and explains how the breeding partner was selected accordingly is demonstrating exactly the kind of transparent, science-based decision-making that health testing is designed to enable.
My puppy’s breeder used Embark panels on the parents. Is that sufficient genetic testing, or is it a replacement for OFA evaluations?
Embark panels and similar commercial DNA health screening tools are a valuable component of a breeding program’s genetic testing, but they are complementary to OFA evaluations rather than replacements for them. Embark tests for genetic variants associated with specific heritable conditions across a large panel of diseases in a single test, which is efficient and cost-effective. What Embark cannot do is evaluate hip joint conformation, elbow joint structure, patellar stability, or retinal health, all of which require physical examination by a veterinary specialist. A breeding program that has Embark panels but no OFA hip, elbow, or CAER eye evaluations has done part of the job. A complete program uses both: DNA panels to identify carrier and at-risk status for conditions with validated genetic tests, and OFA evaluations for the physical structure and health features that require imaging or specialist examination. For Bernedoodle programs specifically, where the Bernese Mountain Dog side adds its own orthopedic disease burden, OFA hip and elbow evaluations of both parent breeds are non-negotiable components of responsible health documentation.
If a Poodle tests clear on every DNA test, does that mean the puppy will be healthy?
No, and being honest about this is important. A clear result on every available DNA test means the dog does not carry the variants that have been identified and validated as associated with specific heritable conditions as of when the tests were run. It does not mean the dog is free of all genetic disease risk, because not every condition has a test, not every variant has been discovered, and some conditions, including Addison’s disease, sebaceous adenitis, bloat, and epilepsy, have a hereditary component that current testing cannot capture. Embark’s guidance for veterinarians is direct on this point: not all breed-relevant conditions currently have a genetic test, and genetic results must be interpreted in the context of a complete physical examination and full clinical history. Health testing reduces known heritable disease risk in well-understood, well-characterized conditions. It does not produce a guarantee of health, and any breeder who implies otherwise is overstating what the science currently supports. What it does produce, when applied rigorously and transparently, is a meaningfully better starting point for a puppy’s health than the alternative of untested parentage. That is a real and significant benefit even when it falls short of a guarantee.
How does health testing of the Poodle parent affect a Bernedoodle puppy’s outcomes?
A Bernedoodle inherits health risks from both parent breeds in proportion to its generation and the specific combination involved, and the Poodle parent’s health profile is directly relevant to roughly half of that inheritance. prcd-PRA and NEwS in Standard Bernedoodles, osteochondrodysplasia in Miniature Bernedoodles, and the full orthopedic picture from both sides all depend on how thoroughly both parents were tested and what those results showed. A Bernedoodle puppy from a Poodle parent with OFA-certified hips and a Bernese Mountain Dog parent with OFA-certified hips has a meaningfully better statistical start for joint health than one from untested parentage. A Bernedoodle from two prcd-PRA-tested parents, both confirmed clear, cannot be affected by prcd-PRA regardless of generation. These are not hypothetical differences: they are the measurable outcomes of the testing decisions breeders make before placing puppies. In our program, we apply the full testing protocol described throughout this guide to all Poodle and Bernese Mountain Dog parents, submit every result to OFA, and provide complete documentation to every family at placement, along with post-placement support as health questions arise across the dog’s life. We would rather have the honest conversation about what testing can and cannot guarantee than place a puppy under a misunderstanding that will become apparent later.
Final Thoughts
Health testing is fundamentally a transparency practice. It is how breeders make their decision-making visible and accountable to the families who trust them enough to buy a puppy, and to the breed’s long-term health trajectory as a whole. The OFA database exists because private assurances between buyers and sellers are not sufficient accountability when the stakes are a dog’s health and a family’s ten-to-fifteen-year commitment. The testing protocols exist because the Poodle Club of America, its foundation, and the veterinary genetics researchers who study this breed have identified specific conditions that responsible breeders can meaningfully reduce through deliberate pairing decisions. Using those tools fully, submitting results publicly, and explaining both what the tests found and what they cannot tell you is what distinguishes a program that takes health testing seriously from one that treats it as a marketing phrase.
For families considering a Poodle or Bernedoodle, this guide is a starting point for the conversation rather than a substitute for it. The questions in the buyer checklist are questions any genuinely transparent breeder should welcome, because they are exactly the questions that demonstrate a buyer who will take good care of what has been placed with them. A breeder who deflects those questions, treats them as an affront, or cannot produce documentation that supports their verbal claims is communicating something important about their program’s actual standards. The families who ask the right questions before bringing a puppy home are the ones who end up with dogs whose health documentation means what it says.